Showing results (221-230 of 240) with videos related to

Sort By:
Pageof 24
Gastroenterology|March 20, 2025
Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants With Moderately to Severely Active Crohn's Disease: Results From the Phase 3 GRAVITI StudyAilsa Hart, Remo Panaccione, Flavio Steinwurz, et al.
Inflammatory Bowel Diseases|May 1, 2026
Five-year efficacy and safety of guselkumab for moderately to severely active Crohn's disease: Results from the phase 2 GALAXI 1 trialAnita Afzali, Silvio Danese, Remo Panaccione, et al.
Journal of the Endocrine Society|May 8, 2023
A Pilot Randomized Clinical Trial of Intranasal Oxytocin to Promote Weight Loss in Individuals With Hypothalamic ObesityShana E McCormack, Zi Wang, Kristin L Wade, et al.
The Journal of Physical Chemistry Letters|May 17, 2016
Negative Pressures and Spallation in Water Drops Subjected to Nanosecond Shock WavesClaudiu A Stan, Philip R Willmott, Howard A Stone, et al.
American Heart Journal|December 21, 2010
Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conferenceWyman W Lai, Victoria L Vetter, Marc Richmond, et al.
American Heart Journal|October 17, 2012
Pediatric cardiovascular safety: challenges in drug and device development and clinical applicationKatherine E Bates, Victoria L Vetter, Jennifer S Li, et al.
Lancet (London, England)|July 20, 2025
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trialsRemo Panaccione, Brian G Feagan, Anita Afzali, et al.
Human Genomics|July 19, 2015
Utility and limitations of exome sequencing as a genetic diagnostic tool for conditions associated with pediatric sudden cardiac arrest/sudden cardiac deathMindy H Li, Jenica L Abrudan, Matthew C Dulik, et al.
Journal of the American College of Cardiology|December 20, 2005
Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter studyAnne M Dubin, Jan Janousek, Edward Rhee, et al.
BMJ Open Gastroenterology|March 23, 2026
Multiomic characterisation of the clinical efficacy of guselkumab induction therapy in ulcerative colitisAmy Hart, Sunandini Sridhar, Swati Venkat, et al.
Pageof 24